[Rod-derived cone viability factor: a clue for therapy of retinitis pigmentosa?]

Med Sci (Paris). 2005 Jan;21(1):22-4. doi: 10.1051/medsci/200521122.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Humans
  • Retinitis Pigmentosa / therapy*
  • Thioredoxins*

Substances

  • NXNL1 protein, human
  • Thioredoxins